Compounds > afdx 116
Page last updated: 2024-09-02

afdx 116 and 6-cyano-7-nitroquinoxaline-2,3-dione

afdx 116 has been researched along with 6-cyano-7-nitroquinoxaline-2,3-dione in 1 studies

Compound Research Comparison

Studies
(afdx 116)		Trials
(afdx 116)		Recent Studies (post-2010)
(afdx 116)		Studies
(6-cyano-7-nitroquinoxaline-2,3-dione)		Trials
(6-cyano-7-nitroquinoxaline-2,3-dione)		Recent Studies (post-2010) (6-cyano-7-nitroquinoxaline-2,3-dione)
3671242,6981353

Protein Interaction Comparison

ProteinTaxonomyafdx 116 (IC50)6-cyano-7-nitroquinoxaline-2,3-dione (IC50)
Glutamate receptor 1Homo sapiens (human)1.02
Glutamate receptor 2Homo sapiens (human)1.02
Glutamate receptor 3Homo sapiens (human)1.02
Glutamate receptor 4Homo sapiens (human)1.02

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jiang, ZG; North, RA; Sugita, S; Uchimura, N1

Other Studies

1 other study(ies) available for afdx 116 and 6-cyano-7-nitroquinoxaline-2,3-dione

ArticleYear
Distinct muscarinic receptors inhibit release of gamma-aminobutyric acid and excitatory amino acids in mammalian brain.
    Proceedings of the National Academy of Sciences of the United States of America, 1991, Mar-15, Volume: 88, Issue:6

    Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; Amygdala; Animals; Brain; Corpus Striatum; Diamines; gamma-Aminobutyric Acid; Glutamates; In Vitro Techniques; Kinetics; Muscarine; Neurons; Nucleus Accumbens; Organ Specificity; Parasympatholytics; Pirenzepine; Quinoxalines; Rats; Receptors, Muscarinic; Synapses

1991